197 related articles for article (PubMed ID: 15304391)
1. Expression of the AID protein in normal and neoplastic B cells.
Pasqualucci L; Guglielmino R; Houldsworth J; Mohr J; Aoufouchi S; Polakiewicz R; Chaganti RS; Dalla-Favera R
Blood; 2004 Nov; 104(10):3318-25. PubMed ID: 15304391
[TBL] [Abstract][Full Text] [Related]
2. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
3. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
Greeve J; Philipsen A; Krause K; Klapper W; Heidorn K; Castle BE; Janda J; Marcu KB; Parwaresch R
Blood; 2003 May; 101(9):3574-80. PubMed ID: 12511417
[TBL] [Abstract][Full Text] [Related]
4. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma.
Greiner A; Tobollik S; Buettner M; Jungnickel B; Herrmann K; Kremmer E; Niedobitek G
J Pathol; 2005 Apr; 205(5):541-7. PubMed ID: 15732141
[TBL] [Abstract][Full Text] [Related]
6. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
7. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
Oppezzo P; Dighiero G
Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
[TBL] [Abstract][Full Text] [Related]
8. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
9. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.
Pasqualucci L; Kitaura Y; Gu H; Dalla-Favera R
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):395-400. PubMed ID: 16387847
[TBL] [Abstract][Full Text] [Related]
10. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
Rückerl F; Bachl J
Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
[TBL] [Abstract][Full Text] [Related]
12. AID in non-Hodgkin B-cell lymphomas: The consequences of on- and off-target activity.
Leeman-Neill RJ; Bhagat G; Basu U
Adv Immunol; 2024; 161():127-164. PubMed ID: 38763700
[TBL] [Abstract][Full Text] [Related]
13. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Nakamachi Y; Kumagai S; Ohno H; Tanabe S; Uchida M; Yasuda N
Leukemia; 2004 Apr; 18(4):826-31. PubMed ID: 14990977
[TBL] [Abstract][Full Text] [Related]
14. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
15. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
16. AID is required for germinal center-derived lymphomagenesis.
Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC; Nussenzweig MC; Dalla-Favera R
Nat Genet; 2008 Jan; 40(1):108-12. PubMed ID: 18066064
[TBL] [Abstract][Full Text] [Related]
17. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
Gu X; Booth CJ; Liu Z; Strout MP
Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
[TBL] [Abstract][Full Text] [Related]
19. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Deutsch AJ; Aigelsreiter A; Staber PB; Beham A; Linkesch W; Guelly C; Brezinschek RI; Fruhwirth M; Emberger W; Buettner M; Beham-Schmid C; Neumeister P
Blood; 2007 Apr; 109(8):3500-4. PubMed ID: 17197434
[TBL] [Abstract][Full Text] [Related]
20. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma.
Gaidano G; Pasqualucci L; Capello D; Berra E; Deambrogi C; Rossi D; Maria Larocca L; Gloghini A; Carbone A; Dalla-Favera R
Blood; 2003 Sep; 102(5):1833-41. PubMed ID: 12714522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
